• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION 213, LLC 0113 CHLORAPREP ONE STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION 213, LLC 0113 CHLORAPREP ONE STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number 930700NSB
Device Problems Contamination /Decontamination Problem (2895); Manufacturing, Packaging or Shipping Problem (2975); No Apparent Adverse Event (3189)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/10/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4) initial emdr submission.A follow up emdr will be submitted if additional information becomes available.(b)(4).
 
Event Description
Material no.: 930700nsb.Batch no.: 0126294.It was reported debris found on the applicator.Per email: per sales rep: debris found on the chloraprep applicator.Picture attached- product.
 
Manufacturer Narrative
A photos has been provided for evaluation.Visual examination of the photo shows black foreign matter (much like black grease).As a result, bd was able to verify the reported issue.The lot number and the expiration date ink are not smeared or runaway.The numbers are clearly readable.The black spot below the numbers seems to be of a thicker viscosity than of the black ink more like a a thicker viscosity grease that might have occurred during post handling fabrication, assembly, or kitting.No further actions are required at this time.This failure mode will continue to be tracked and trended.H3 other text : see narrative below.
 
Event Description
It was reported debris found on the applicator.Per sales rep: debris found on the chloraprep applicator.
 
Manufacturer Narrative
A photo has been provided for evaluation.Visual examination of the photo shows black foreign matter (much like black grease).As a result, bd was able to verify the reported issue.The black spot below the numbers seems to be of a thicker viscosity than of the black ink, such as grease.Bd¿s production equipment does not utilize grease or grease-like material therefore this foreign matter may have originated after leaving bd¿s control.A device history review was completed and no non-conformances we¿re identified during the manufacturing of this lot.In addition, this is the first reported issue that has been sent in for pn 930700nsb and lot.This is considered an isolated/rare occurrence.No further action is planned at this time.This failure mode will continue to be tracked and trended.
 
Event Description
It was reported debris found on the applicator.Per email: per sales rep: debris found on the chloraprep applicator.Picture attached- product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHLORAPREP ONE STEP
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION 213, LLC 0113
1550 northwestern dr
el paso TX 79912
MDR Report Key11152213
MDR Text Key226793706
Report Number3004932373-2020-00177
Device Sequence Number1
Product Code KXG
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other
Type of Report Initial,Followup,Followup
Report Date 06/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date01/30/2023
Device Catalogue Number930700NSB
Device Lot Number0126294
Initial Date Manufacturer Received 12/16/2020
Initial Date FDA Received01/11/2021
Supplement Dates Manufacturer Received03/08/2021
03/08/2021
Supplement Dates FDA Received03/08/2021
06/14/2021
Patient Sequence Number1
Patient Outcome(s) Other;
-
-